Roche, Hansoh Launch Up-to-$15B+ Cancer ADC Collaboration
Roche and Hansoh Pharmaceutical Group have launched their second collaboration focused on developing cancer-fighting antibody-drug conjugates (ADCs), a partnership that could generate more than $15 billion for the Shanghai-based drug developer. Roche and …